Acella Pharmaceuticals is voluntarily recalling certain lots NP Thyroid tablets after testing found them to be “superpotent.”
According to CBS New York, patients who are taking NP Thyroid for hypothyroidism (underactive thyroid), may experience the following symptoms of hyperthyroidism (overactive thyroid):
The company says the affected products may contain up to 115% of the labeled amount of Liothyronine. They also noted that pregnant women who have taken the drug may experience negative maternal and fetal outcomes, including miscarriage or “impairment to fetal development.”
Patients are advised to contact their doctors for a replacement prescription before discontinuing use.
The recall includes 13 lots of 30-mg, 60-mg, and 90-mg tablets which were packaged in 100-count bottles. The following lot numbers are affected:
Patients with questions about the recall can email Acella Pharmaceuticals at firstname.lastname@example.org or contact Acella Customer Service at 1-800-541-4802, Monday through Thursday from 9:00 am to 5:00 pm ET and Friday from 9:00 am to 12:30 pm ET.
If you or a loved one has been the victim of a dangerous pharmaceutical drug or medical device, you may be entitled to compensation. You deserve dynamic representation from a law firm with the resources necessary to take on the pharmaceutical companies. Thomas J. Henry has a track record of helping clients receive record-breaking verdicts, settlements, and judgments.